Theratechnologies Inc T.TH

14th world ADC

[scarlet1967]

The CMO will be speaking at this upcoming conference.

https://storage.pardot.com/448062/1683823932zocy9mza/14th_World_ADC_San_Diego_brochure___Official_Event_Guide_2023.pdf

[scarlet1967]

1:30 Improving the Therapeutic Window of Anti-Cancer Therapeutics: Exploiting the Scavenger Property of the Sortilin (SORT1) Receptor to Enable Targeted Delivery of Peptide Drug Conjugates (PDC’s) Christian Marsolais, Senior Vice President & Chief Medical Officer,Theratechnologies

[Mannequin]

Turning cold Tumors into hot Tumors  BTW here is a new article which mentions TH1902  https://www.nature.com/articles/s12276-023-01016-x.pdf    

[Trogarzon]

All good for visability and stock price but does'nt translate into shareholder value.  Probably never will with this board and management.  Build it and they will come does'nt apply to biotech because you need money to build a great company.  They never understood this and badly neglected the retail shareholder.  Big costly mistake.

[Wino115]

That's quite a good article comparing PDCs/ADCs and who the players are. Makes you wonder that if you can just show the key benefits working (much quicker internalization, more internalized into cell, lower effect on bones, etc.., better tolerance) that the chemo doesn't really matter as far as attracting a commercial partner. If your target works, the pepetide works for it's role